OTC Switch Public Policy, Science Issues Workshop Proposed
This article was originally published in The Tan Sheet
Executive Summary
The idea of a public workshop to address certain issues related to the Rx-to-OTC switch process was generally supported by industry representatives and FDAers at a switch summit held by the Consumer Healthcare Products Association in Washington, D.C. July 16.
You may also be interested in...
Healthcare "Rationing" Not Acceptable Reason For Denying Switches - FDAer
The practice of "rationing" a drug, or wanting to keep it out of the hands of the general public, is not an acceptable singular reason for disapproving a switch candidate, FDA Office of Drug Evaluation V Director Robert DeLap, MD/PhD, stated at a switch summit held by the Consumer Healthcare Products Association July 16 in Washington, D.C.
Healthcare "Rationing" Not Acceptable Reason For Denying Switches - FDAer
The practice of "rationing" a drug, or wanting to keep it out of the hands of the general public, is not an acceptable singular reason for disapproving a switch candidate, FDA Office of Drug Evaluation V Director Robert DeLap, MD/PhD, stated at a switch summit held by the Consumer Healthcare Products Association July 16 in Washington, D.C.
Healthcare "Rationing" Not Acceptable Reason For Denying Switches - FDAer
The practice of "rationing" a drug, or wanting to keep it out of the hands of the general public, is not an acceptable singular reason for disapproving a switch candidate, FDA Office of Drug Evaluation V Director Robert DeLap, MD/PhD, stated at a switch summit held by the Consumer Healthcare Products Association July 16 in Washington, D.C.